ReachBio LLC© provides specialized Drug Development Services (in vitro and in vivo) and products to life science organizations worldwide. The company’s focus is on the use of primary cell systems for high value applications such as drug discovery & screening and toxicity testing.

Their platform is broad and includes predictive and investigative toxicology, efficacy testing, cell bank development, biomarker selection, flow cytometry/cell sorting, immune profiling, cancer immunoassay development, biotherapeutics development support, molecular biology services, cancer stem cell assays, cytokine & mimetic detection, evaluation of mobilizing agents and customized cell biology services. They also offer specialized media for hematopoietic and mesenchymal stem cell culture and cancer stem cell assays. Their cell products include various subsets derived from primary human whole blood, mobilized blood, cord blood and bone marrow alone with custom cell preparation services.